Notice of Closed Meeting, 30706 [2020-10890]

Download as PDF 30706 Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices EARLY TERMINATIONS GRANTED APRIL 1, 2020 THRU APRIL 30, 2020—Continued 04/22/2020 20200814 ...... 20200976 ...... 20200995 ...... G G G AIPCF VI Stone Cayman AIV, LP; GATX Corporation; AIPCF VI Stone Cayman AIV, LP. GlaxoSmithKline plc; Vir Biotechnology, Inc.; GlaxoSmithKline plc. Pfizer Inc.; ATHOS KG; Pfizer Inc. 04/23/2020 20200970 ...... G Charlesbank Equity Fund IX, Limited Partnership; News Corporation; Charlesbank Equity Fund IX, Limited Partnership. 04/27/2020 20200987 ...... 20200991 ...... 20200996 ...... G G G INTL FCStone Inc.; GAIN Capital Holdings, Inc.; INTL FCStone Inc. Verizon Communications Inc.; Blue Jeans Network, Inc.; Verizon Communications Inc. Roark Capital Partners V (T) LP; The Cheesecake Factory Incorporated; Roark Capital Partners V (T) LP. 04/29/2020 20200784 ...... G Leidos Holdings, Inc.; L3Harris Technologies, Inc.; Leidos Holdings, Inc. FOR FURTHER INFORMATION CONTACT: Theresa Kingsberry (202–326–3100), Program Support Specialist, Federal Trade Commission Premerger Notification Office, Bureau of Competition, Room CC–5301, Washington, DC 20024. By direction of the Commission. April J. Tabor, Acting Secretary. [FR Doc. 2020–10883 Filed 5–19–20; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA–CE–20–002, Grants to Support VerDate Sep<11>2014 17:51 May 19, 2020 Jkt 250001 New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth. Date: June 10–11, 2020. Time: 8:30 a.m.–5:30 p.m., EDT. Place: Zoom Video Conference/ Teleconference. Agenda:To review and evaluate grant applications. For Further Information Contact: Mikel Walters, Ph.D., Scientific Review Official, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Building 106, MS S106–9, Atlanta, Georgia 30341, Telephone (404) 639–0913, MWalters@ cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–10890 Filed 5–19–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 84 FR 65981, dated December 2, 2019) is amended to reflect the reorganization of the National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention. The reorganization is needed to become more responsive to the changing mining industry and stakeholder priorities, as well as align and integrate regional activities of the NIOSH mining program’s core business and research functions. I. Under Part C, Section C–B, Organization and Functions, the following organizational units are deleted in their entirety: • Health Communication, Surveillance and Research Support Branch (CCRB) • Ground Control Branch (CCRC) • Dust, Ventilation and Toxic Substances Branch (CCRD) • Human Factors Branch (CCRE) • Electrical and Mechanical Systems Safety Branch (CCRF) • Fires and Explosions Branch (CCRG) • Workplace Health Branch (CCRH) II. Under Part C, Section C–B, Organization and Functions, make the following changes: • Update functional statement for the Pittsburgh Mining Research Division (CCR) • Create the Health Hazards Prevention Branch (CCRJ) • Create the Mining Systems Safety Branch (CCRK) • Create the Human Systems Integration Branch (CCRL) • Update the functional statement for the Spokane Research Division (CCS) E:\FR\FM\20MYN1.SGM 20MYN1

Agencies

[Federal Register Volume 85, Number 98 (Wednesday, May 20, 2020)]
[Notices]
[Page 30706]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10890]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-CE-20-002, Grants to Support 
New Investigators in Conducting Research Related to Preventing 
Interpersonal Violence Impacting Children and Youth.
    Date: June 10-11, 2020.
    Time: 8:30 a.m.-5:30 p.m., EDT.
    Place: Zoom Video Conference/Teleconference.
    Agenda:To review and evaluate grant applications.
    For Further Information Contact: Mikel Walters, Ph.D., Scientific 
Review Official, National Center for Injury Prevention and Control, 
CDC, 4770 Buford Highway NE, Building 106, MS S106-9, Atlanta, Georgia 
30341, Telephone (404) 639-0913, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-10890 Filed 5-19-20; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.